About this trial
This a single-center, retrospective, observational study of patients that undergo coronary sinus(CS) lead revision, comparing epicardial lead placement to coronary sinus pacing(CSP) in those that had lead failure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients older than 18 years of age
Patients with HFrEF that underwent BVP-CRT
Experienced CS lead failure, whether initial or recurrent, subsequently replaced with transthoracic epicardial lead placement or CSP
Underwent Medtronic, Boston Scientific, or Abbott lead placement
Disqualifiers
Patients younger than 18 years of age
Transthoracic epicardial lead placement or CSP performed as the initial approach or for other reasons than lead replacement
Those for which CRT no longer provides symptom relief or mortality benefit.
Trial population
Adults who underwent CS lead revision, comparing epicardial lead placement to CSP in those that had lead failure.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Coronary Sinus Lead Revision
Other interventionCoronary Sinus Lead Revision
Treatment groups
Trial outcomes
Primary outcomes
Need for lead revision
Compare the need for lead revision between conduction system pacing (CSP) and transthoracic left ventricular (LV) epicardial pacing approach
Secondary outcomes
Electrocardiography characteristics - QRS Interval
Compare electrocardiography characteristics - QRS Interval measured in seconds between conduction system pacing (CSP) and transthoracic left ventricular (LV) epicardial pacing approach
Sponsors and contacts
Click on the lead sponsor to view all of their trials.